HEMOGLOBIN OXYGEN THERAPEUTICS LLC secures contract for Notice Of Intent To Sole Source: Canine Oxygen Carrier Manufacturing Restoration And Regulatory Activities An13 - Health R&D Services; Health Care Services; Experimental Development 541715 - Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)

United States, May 28 -- United States based HEMOGLOBIN OXYGEN THERAPEUTICS LLC has secured contract from Dept Of Defense for Notice Of Intent To Sole Source: Canine Oxygen Carrier Manufacturing Restoration And Regulatory Activities An13 - Health R&D Services; Health Care Services; Experimental Development 541715 - Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology) . The value of the contract is worth 12534579 USD.

Published by HT Digital Content Services with permission from Pivotal Sources....